Omega Therapeutics Inc (OMGA)
1.32
+0.06
(+4.76%)
USD |
NASDAQ |
Sep 27, 16:00
1.31
-0.01
(-0.76%)
Pre-Market: 20:00
Omega Therapeutics Enterprise Value: 43.86M for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 43.86M |
| September 26, 2024 | 40.55M |
| September 25, 2024 | 40.55M |
| September 24, 2024 | 43.86M |
| September 23, 2024 | 44.41M |
| September 20, 2024 | 46.62M |
| September 19, 2024 | 49.38M |
| September 18, 2024 | 49.93M |
| September 17, 2024 | 46.07M |
| September 16, 2024 | 44.41M |
| September 13, 2024 | 44.41M |
| September 12, 2024 | 39.45M |
| September 11, 2024 | 40.00M |
| September 10, 2024 | 40.00M |
| September 09, 2024 | 38.90M |
| September 06, 2024 | 38.35M |
| September 05, 2024 | 46.07M |
| September 04, 2024 | 47.17M |
| September 03, 2024 | 46.62M |
| August 30, 2024 | 52.13M |
| August 29, 2024 | 51.58M |
| August 28, 2024 | 51.03M |
| August 27, 2024 | 52.13M |
| August 26, 2024 | 54.34M |
| August 23, 2024 | 56.55M |
| Date | Value |
|---|---|
| August 22, 2024 | 54.89M |
| August 21, 2024 | 58.20M |
| August 20, 2024 | 56.00M |
| August 19, 2024 | 57.10M |
| August 16, 2024 | 53.24M |
| August 15, 2024 | 55.44M |
| August 14, 2024 | 51.58M |
| August 13, 2024 | 53.79M |
| August 12, 2024 | 52.13M |
| August 09, 2024 | 55.44M |
| August 08, 2024 | 56.55M |
| August 07, 2024 | 55.44M |
| August 06, 2024 | 61.79M |
| August 05, 2024 | 56.00M |
| August 02, 2024 | 60.96M |
| August 01, 2024 | 66.48M |
| July 31, 2024 | 73.65M |
| July 30, 2024 | 73.09M |
| July 29, 2024 | 75.30M |
| July 26, 2024 | 76.95M |
| July 25, 2024 | 73.09M |
| July 24, 2024 | 72.54M |
| July 23, 2024 | 77.51M |
| July 22, 2024 | 73.09M |
| July 19, 2024 | 69.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-84.74M
Minimum
Jun 01 2022
1.181B
Maximum
Oct 29 2021
219.41M
Average
139.09M
Median
Sep 26 2022
Enterprise Value Benchmarks
| Moderna Inc | 16.79B |
| NovaBay Pharmaceuticals Inc | 3.420M |
| Palatin Technologies Inc | 6.268M |
| iBio Inc | 4.741M |
| Theriva Biologics Inc | -13.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.30M |
| Revenue (Quarterly) | 2.134M |
| Total Expenses (Quarterly) | 18.71M |
| EPS Diluted (Quarterly) | -0.30 |
| Profit Margin (Quarterly) | -764.1% |
| Earnings Yield | -107.6% |
| Normalized Earnings Yield | -107.58 |